⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABUS News
Arbutus Biopharma Corporation Common Stock
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
globenewswire.com
ABUS
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
globenewswire.com
ABUS
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
globenewswire.com
ABUS
Form 8-K
sec.gov
ABUS
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
globenewswire.com
ABUS
2026 RNAi Drug Delivery Market Report: Global Revenues to Reach $3.34 Billion by 2031, Driven by siRNA Approvals and Delivery Platform Innovation
globenewswire.com
ALNY
ARWR
ABUS
PFE
AZN
IONS
MRK
NVO
ROG
SNY
SLN
TAK
Form 8-K
sec.gov
ABUS
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ABUS
Form 8-K
sec.gov
ABUS
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
globenewswire.com
ABUS
ROIV
PFE
BNTX
MRNA